Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent LeasesCurrent TaxesDividends payablesFinished GoodsGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current DebtOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPreferred Stock LiabilitiesPrepaid AssetsProperty, Plant & Equipment (Net)Raw MaterialsReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Envoy Medical (COCH) Non-Current Deffered Revenue (2022 - 2023)

Historic Non-Current Deffered Revenue for Envoy Medical (COCH) over the last 2 years, with Q2 2023 value amounting to $10.4 million.

  • Envoy Medical's Non-Current Deffered Revenue fell 3000.0% to $10.4 million in Q2 2023 from the same period last year, while for Jun 2023 it was $10.4 million, marking a year-over-year decrease of 3000.0%. This contributed to the annual value of $10.4 million for FY2022, which is N/A changed from last year.
  • Latest data reveals that Envoy Medical reported Non-Current Deffered Revenue of $10.4 million as of Q2 2023, which was down 3000.0% from $10.4 million recorded in Q1 2023.
  • Envoy Medical's Non-Current Deffered Revenue's 5-year high stood at $14.9 million during Q1 2022, with a 5-year trough of $10.4 million in Q3 2022.